Pharmacokinetics and preventive effects of platinum nanoparticles as reactive oxygen species scavengers on hepatic metastasis

• In: Short Communications B3 on Tuesday, 23 May 2017, 11:15-12:30
• At: Stockholm (Sweden) (2017)
• Type: Presentation
• By: KATSUMI, Hidemasa (Kyoto Pharmaceutical University, Biopharmaceutis, Kyoto, Japan)
• Co-author(s): Hidemasa Katsumi: Biopharmaceutis, Kyoto Pharmaceutical University, Kyoto, Japan
  Shoko Maruyama: Biopharmaceutis, Kyoto Pharmaceutical University, Kyoto, Japan
  Kosuke Kusamori: Biopharmaceutis, Kyoto Pharmaceutical University, Kyoto, Japan
  Sakane Toshiyasu: Biopharmaceutis, Kyoto Pharmaceutical University, Kyoto, Japan;Pharmaceutical Technology, Kobe Pharmaceutical University, Kobe, Japan
  Akira Yamamoto: Biopharmaceutis, Kyoto Pharmaceutical University, Kyoto, Japan
  
• Abstract:

  Backgrounds

  Oxidative stress is recognized as being involved in the pathogenesis of hepatic metastasis. Therefore, reactive oxygen species (ROS) scavengers have been considered as therapeutic agents for hepatic metastasis. We have recently developed citric acid-protected platinum nanoparticles (Pt-NPs) with ROS-scavenging properties for the

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login